Lixte Biotechnology
LIXT
LIXT
15 hedge funds and large institutions have $652K invested in Lixte Biotechnology in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less capital invested
Capital invested by funds: $1.49M → $652K (-$833K)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$102K | |
| 2 | +$58.3K | |
| 3 | +$30.7K | |
| 4 |
Two Sigma Investments
New York
|
+$17.3K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$14.8K |
Top Sellers
| 1 | -$506K | |
| 2 | -$31K | |
| 3 | -$16K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$15.5K |
| 5 |
Jane Street
New York
|
-$7.08K |